A PMHNP is initiating lithium therapy for a 40-year-old man newly diagnosed with bipolar I disorder following a manic episode with psychotic features. The patient is now stable and has decision-making capacity. Before writing the prescription, the PMHNP must obtain informed consent. She considers what elements are legally and ethically required for valid informed consent for this medication with significant monitoring requirements and potential toxicity.